The United States has been caught off guard by a new adversary from abroad, the NB.1.81 variant of COVID-19.
See the tweet below!
Hailing from China and Hong Kong, this variant has found its way through our airports, posing a familiar threat to the well-being of American citizens.
As the CDC scrambles to monitor the few cases detected, the situation leaves us questioning whether our defenses are strong enough to prevent another crisis.
The Centers for Disease Control and Prevention (CDC) has identified the NB.1.81 variant in several U.S. states, evident from the international travelers who have brought it from Asia.
Airports in California, Washington, Virginia, and New York City reported the variant’s presence between late March and early April.
The strain’s emergence coincides with a significant spike of cases in China, where hospitalization rates have alarmingly risen.
As of now, fewer than 20 sequences of this variant have been identified in the U.S., which explains its absence from the CDC’s COVID Data Tracker dashboard.
The CDC confirms that if leading cases increase, it will appear on the dashboard for regular surveillance.
This cautious approach points to an understanding of previous pandemic challenges and a strategy to prevent catastrophic consequences.
China provides a cautionary example: COVID-19 emergency room visits doubled within a mere month.
With infections rising beyond 16%, hospital capacities are being severely tested.
The NB.1.81 variant makes up a significant part of these statistics, as observed in both China and Hong Kong.
The international nature of this variant demonstrates that its spread isn’t isolated, emphasizing the need for robust strategies at every level of American public health.
In response to its initial spread through travelers from countries including Japan, South Korea, France, and others, the CDC is maintaining direct talks with international counterparts to stay ahead of further outbreaks.
However, fewer than expected cases in the US could imply possible resistance due to existing immunity levels within the American population.
Former federal COVID response coordinators assure that this immunity predicates a lower probability of surges, though no outcome is guaranteed.
Health authorities have issued a high alert for medical professionals due to the rapid spread of the new COVID-19 variant NB.1.81 across Asia and parts of the US.
— Arbiterz NG (@ArbiterzNigeria) May 28, 2025
Some worry the variant may evade existing COVID vaccine protections.
This uncertainty fuels debate surrounding the future need for booster vaccinations, particularly among seniors and high-risk groups.
The Trump administration proposes limiting these annual doses, aiming to avoid unwarranted health interventions while safeguarding vulnerable populations.
With the fall approaching, federal agencies consider adjusting vaccine compositions for better effectiveness against new strains.
